Fidelity Investments’s Atara Biotherapeutics ATRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $132K | Sell |
17,156
-1
| -0% | -$8 | ﹤0.01% | 3482 |
|
|
2025
Q1 | $102K | Sell |
17,157
-9,542
| -36% | -$56.7K | ﹤0.01% | 3548 |
|
|
2024
Q4 | $355K | Buy |
26,699
+1,638
| +7% | +$21.8K | ﹤0.01% | 3043 |
|
|
2024
Q3 | $204K | Buy |
25,061
+7,381
| +42% | +$60K | ﹤0.01% | 3184 |
|
|
2024
Q2 | $150K | Sell |
17,680
-392,998
| -96% | -$3.34M | ﹤0.01% | 3141 |
|
|
2024
Q1 | $285K | Sell |
410,678
-54,037
| -12% | -$37.5K | ﹤0.01% | 2903 |
|
|
2023
Q4 | $238K | Buy |
464,715
+229,176
| +97% | +$118K | ﹤0.01% | 2907 |
|
|
2023
Q3 | $349K | Buy |
235,539
+11,832
| +5% | +$17.5K | ﹤0.01% | 2726 |
|
|
2023
Q2 | $360K | Buy |
223,707
+95,158
| +74% | +$153K | ﹤0.01% | 2764 |
|
|
2023
Q1 | $373K | Sell |
128,549
-3,972
| -3% | -$11.5K | ﹤0.01% | 2791 |
|
|
2022
Q4 | $435K | Sell |
132,521
-83,597
| -39% | -$274K | ﹤0.01% | 2758 |
|
|
2022
Q3 | $817K | Sell |
216,118
-5,629,942
| -96% | -$21.3M | ﹤0.01% | 2657 |
|
|
2022
Q2 | $45.5M | Buy |
5,846,060
+99,320
| +2% | +$774K | ﹤0.01% | 1306 |
|
|
2022
Q1 | $53.4M | Buy |
5,746,740
+133,498
| +2% | +$1.24M | ﹤0.01% | 1365 |
|
|
2021
Q4 | $88.5M | Buy |
5,613,242
+1,130,696
| +25% | +$17.8M | 0.01% | 1161 |
|
|
2021
Q3 | $80.2M | Buy |
4,482,546
+3,044,774
| +212% | +$54.5M | 0.01% | 1198 |
|
|
2021
Q2 | $22.4M | Sell |
1,437,772
-274,023
| -16% | -$4.26M | ﹤0.01% | 1806 |
|
|
2021
Q1 | $24.6M | Sell |
1,711,795
-92,200
| -5% | -$1.32M | ﹤0.01% | 1718 |
|
|
2020
Q4 | $35.4M | Sell |
1,803,995
-192,378
| -10% | -$3.78M | ﹤0.01% | 1466 |
|
|
2020
Q3 | $25.9M | Sell |
1,996,373
-15,207
| -0.8% | -$197K | ﹤0.01% | 1460 |
|
|
2020
Q2 | $29.3M | Buy |
2,011,580
+1,338,395
| +199% | +$19.5M | ﹤0.01% | 1393 |
|
|
2020
Q1 | $5.73M | Sell |
673,185
-1,505
| -0.2% | -$12.8K | ﹤0.01% | 1885 |
|
|
2019
Q4 | $11.1M | Sell |
674,690
-840,435
| -55% | -$13.8M | ﹤0.01% | 1810 |
|
|
2019
Q3 | $21.4M | Sell |
1,515,125
-2,999,738
| -66% | -$42.4M | ﹤0.01% | 1550 |
|
|
2019
Q2 | $90.8M | Sell |
4,514,863
-1,903,093
| -30% | -$38.3M | 0.01% | 952 |
|
|
2019
Q1 | $255M | Buy |
6,417,956
+1,143,787
| +22% | +$45.5M | 0.03% | 556 |
|
|
2018
Q4 | $183M | Buy |
5,274,169
+93,432
| +2% | +$3.25M | 0.03% | 628 |
|
|
2018
Q3 | $214M | Sell |
5,180,737
-953,690
| -16% | -$39.4M | 0.02% | 648 |
|
|
2018
Q2 | $225M | Sell |
6,134,427
-62,135
| -1% | -$2.28M | 0.03% | 612 |
|
|
2018
Q1 | $242M | Buy |
6,196,562
+4,362,694
| +238% | +$170M | 0.03% | 611 |
|
|
2017
Q4 | $33.2M | Buy |
1,833,868
+30,700
| +2% | +$556K | ﹤0.01% | 1486 |
|
|
2017
Q3 | $29.8M | Sell |
1,803,168
-103,200
| -5% | -$1.71M | ﹤0.01% | 1548 |
|
|
2017
Q2 | $26.7M | Sell |
1,906,368
-59,400
| -3% | -$832K | ﹤0.01% | 1557 |
|
|
2017
Q1 | $40.4M | Sell |
1,965,768
-816,679
| -29% | -$16.8M | 0.01% | 1420 |
|
|
2016
Q4 | $39.5M | Sell |
2,782,447
-751,956
| -21% | -$10.7M | 0.01% | 1406 |
|
|
2016
Q3 | $75.6M | Buy |
3,534,403
+408,996
| +13% | +$8.75M | 0.01% | 1115 |
|
|
2016
Q2 | $70.4M | Buy |
3,125,407
+720,313
| +30% | +$16.2M | 0.01% | 1127 |
|
|
2016
Q1 | $45.8M | Buy |
2,405,094
+319,304
| +15% | +$6.08M | 0.01% | 1285 |
|
|
2015
Q4 | $55.1M | Buy |
2,085,790
+481,709
| +30% | +$12.7M | 0.01% | 1222 |
|
|
2015
Q3 | $50.4M | Buy |
1,604,081
+606,122
| +61% | +$19.1M | 0.01% | 1243 |
|
|
2015
Q2 | $52.7M | Buy |
997,959
+304,126
| +44% | +$16M | 0.01% | 1317 |
|
|
2015
Q1 | $28.8M | Sell |
693,833
-654,182
| -49% | -$27.2M | ﹤0.01% | 1592 |
|
|
2014
Q4 | $36.1M | Buy |
+1,348,015
| New | +$36.1M | ﹤0.01% | 1481 |
|